D.E. Shaw & Co
ORGS

D.E. Shaw & Co’s Orgenesis Inc. Common Stock ORGS Stock Holding History

D.E. Shaw & Co’s Portfolio ORGS Stock Details ORGS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-2,505
Closed -$61K – 5611
2022
Q2 		$61K Hold
2,505
– – ﹤0.01% 4808
2022
Q1 		$87K Sell
2,505
-10
-0.4% -$304 ﹤0.01% 5028
2021
Q4 		$72K Sell
2,515
-845
-25% -$33.1K ﹤0.01% 5132
2021
Q3 		$166K Buy
+3,360
New +$169K ﹤0.01% 4610

Other funds holding ORGS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RC
Ronit Capital London, United Kingdom $74.3M AUM 13.35% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BHB
Bank Hapoalim BM Tel Aviv, Israel $652M AUM 19.01% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

D.E. Shaw & Co's ORGS Position: Q3 2022 in Review

D.E. Shaw & Co sold out of Orgenesis Inc. Common Stock (ORGS) in Q3 2022, closing a stake of 2,505 shares — an estimated $61K sold.

D.E. Shaw & Co first reported a position in ORGS in Q3 2021 and held it in 4 quarters. The position peaked at $166K in Q3 2021. 22 funds tracked by Wall St. Rank hold ORGS as of Q3 2022.

  • D.E. Shaw & Co reported no remaining Orgenesis Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 2,505 Orgenesis Inc. Common Stock shares in Q3 2022, an estimated $61K.
  • D.E. Shaw & Co first reported a position in Orgenesis Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • D.E. Shaw & Co's Orgenesis Inc. Common Stock position peaked at $166K in Q3 2021.
  • 22 funds tracked by Wall St. Rank held Orgenesis Inc. Common Stock as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.